We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current VACBF market cap is 489.82M. The company's latest EPS is USD -0.1309 and P/E is -11.46.
| Year End 31 December 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.41M | 215.7M | 35.77M | 9.03M |
| Operating Income | -13.94M | 178.27M | -10.78M | -53.16M |
| Net Income | -13.7M | 149.77M | -9.41M | -42.74M |
| Year End 31 December 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 33.39M | 230.03M | 265.56M | 221.48M |
| Total Liabilities | 5.76M | 51.18M | 71.5M | 64.46M |
| Total Equity | 27.63M | 178.85M | 194.06M | 157.02M |
| Year End 31 December 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.49M | 180.27M | 1.16M | -20.7M |
| Investing | -9.06M | -6.02M | 10.75M | 11.05M |
| Financing | 25.87M | -289k | 20.44M | 360k |
| Market Cap | 489.82M |
| Price to Earnings Ratio | -11.46 |
| Price to Sales Ratio | 54.35 |
| Price to Cash Ratio | 2.38 |
| Price to Book Ratio | 3.12 |
| Dividend Yield | - |
| Shares Outstanding | 326.55M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 5.23k |
| 52 Week Change | -36.44% |
| 52 Week High | 2.36 |
| 52 Week Low | 1.25 |
| Spread (Intraday) | 9.6k (99.99%) |
| Company Name | Nykode Therapeutics AS (PK) |
| Address |
gaustadalleen 21 oslo NO-0349 |
| Website | https://www.nykode.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
